vs
FRESH DEL MONTE PRODUCE INC（FDP）与ICU MEDICAL INC（ICUI）财务数据对比。点击上方公司名可切换其他公司
FRESH DEL MONTE PRODUCE INC的季度营收约是ICU MEDICAL INC的1.9倍（$1.0B vs $540.7M），FRESH DEL MONTE PRODUCE INC净利率更高（1.0% vs -2.9%，领先3.9%），FRESH DEL MONTE PRODUCE INC同比增速更快（-4.9% vs -14.1%），过去两年ICU MEDICAL INC的营收复合增速更高（-2.3% vs -4.3%）
鲜德尔蒙农产品公司是全球领先的垂直一体化生鲜及鲜切果蔬、加工果蔬生产、分销及营销企业，注册地位于开曼群岛乔治敦，美国行政总部设在佛罗里达州科勒尔盖布尔斯塞维利亚大道241号。
ICU医疗是总部位于美国加利福尼亚州圣克莱门特的医疗科技企业，专注于研发预防血流感染、保护医护人员免受传染病或危险药物侵害的医疗产品，产品线覆盖静脉治疗用品、输液泵、无针血管通路设备、定制输液套装、危险药物密闭处理系统、传感导管以及无针封闭式血液采样系统等。
FDP vs ICUI — 直观对比
营收规模更大
FDP
是对方的1.9倍
$540.7M
营收增速更快
FDP
高出9.2%
-14.1%
净利率更高
FDP
高出3.9%
-2.9%
两年增速更快
ICUI
近两年复合增速
-4.3%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $1.0B | $540.7M |
| 净利润 | $10.7M | $-15.7M |
| 毛利率 | 8.5% | 37.5% |
| 营业利润率 | 1.9% | 1.0% |
| 净利率 | 1.0% | -2.9% |
| 营收同比 | -4.9% | -14.1% |
| 净利润同比 | -67.8% | 34.0% |
| 每股收益（稀释后） | $0.21 | $-0.63 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收FDPICUI
| Q1 26 | $1.0B | — | ||
| Q4 25 | $1.0B | $540.7M | ||
| Q3 25 | $1.0B | $537.0M | ||
| Q2 25 | $1.2B | $548.9M | ||
| Q1 25 | $1.1B | $604.7M | ||
| Q4 24 | $1.0B | $629.8M | ||
| Q3 24 | $1.0B | $589.1M | ||
| Q2 24 | $1.1B | $596.5M |
净利润FDPICUI
| Q1 26 | $10.7M | — | ||
| Q4 25 | $32.3M | $-15.7M | ||
| Q3 25 | $-29.1M | $-3.4M | ||
| Q2 25 | $56.8M | $35.3M | ||
| Q1 25 | $31.1M | $-15.5M | ||
| Q4 24 | $20.3M | $-23.8M | ||
| Q3 24 | $42.1M | $-33.0M | ||
| Q2 24 | $53.6M | $-21.4M |
毛利率FDPICUI
| Q1 26 | 8.5% | — | ||
| Q4 25 | 10.4% | 37.5% | ||
| Q3 25 | 7.9% | 37.4% | ||
| Q2 25 | 10.2% | 37.9% | ||
| Q1 25 | 8.4% | 34.7% | ||
| Q4 24 | 6.8% | 36.1% | ||
| Q3 24 | 9.2% | 34.8% | ||
| Q2 24 | 9.9% | 34.8% |
营业利润率FDPICUI
| Q1 26 | 1.9% | — | ||
| Q4 25 | 4.5% | 1.0% | ||
| Q3 25 | -2.1% | 2.6% | ||
| Q2 25 | 5.8% | 1.9% | ||
| Q1 25 | 4.1% | 2.1% | ||
| Q4 24 | 3.0% | 6.0% | ||
| Q3 24 | 5.3% | 1.4% | ||
| Q2 24 | 6.0% | 1.3% |
净利率FDPICUI
| Q1 26 | 1.0% | — | ||
| Q4 25 | 3.2% | -2.9% | ||
| Q3 25 | -2.8% | -0.6% | ||
| Q2 25 | 4.8% | 6.4% | ||
| Q1 25 | 2.8% | -2.6% | ||
| Q4 24 | 2.0% | -3.8% | ||
| Q3 24 | 4.1% | -5.6% | ||
| Q2 24 | 4.7% | -3.6% |
每股收益（稀释后）FDPICUI
| Q1 26 | $0.21 | — | ||
| Q4 25 | $0.67 | $-0.63 | ||
| Q3 25 | $-0.61 | $-0.14 | ||
| Q2 25 | $1.18 | $1.43 | ||
| Q1 25 | $0.64 | $-0.63 | ||
| Q4 24 | $0.41 | $-0.97 | ||
| Q3 24 | $0.88 | $-1.35 | ||
| Q2 24 | $1.12 | $-0.88 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $66.3M | — |
| 总债务越低越好 | $451.5M | — |
| 股东权益账面价值 | $2.0B | $2.1B |
| 总资产 | $3.4B | $4.1B |
| 负债/权益比越低杠杆越低 | 0.22× | — |
8季度趋势，按日历期对齐
现金及短期投资FDPICUI
| Q1 26 | $66.3M | — | ||
| Q4 25 | $35.7M | — | ||
| Q3 25 | $97.2M | — | ||
| Q2 25 | $85.5M | — | ||
| Q1 25 | $34.4M | — | ||
| Q4 24 | $32.6M | $308.6M | ||
| Q3 24 | $50.8M | $312.5M | ||
| Q2 24 | $37.8M | $302.6M |
总债务FDPICUI
| Q1 26 | $451.5M | — | ||
| Q4 25 | $176.2M | — | ||
| Q3 25 | $176.7M | — | ||
| Q2 25 | $205.2M | — | ||
| Q1 25 | $237.4M | — | ||
| Q4 24 | $248.9M | — | ||
| Q3 24 | $274.8M | — | ||
| Q2 24 | $290.4M | — |
股东权益FDPICUI
| Q1 26 | $2.0B | — | ||
| Q4 25 | $2.0B | $2.1B | ||
| Q3 25 | $2.0B | $2.1B | ||
| Q2 25 | $2.1B | $2.1B | ||
| Q1 25 | $2.0B | $2.0B | ||
| Q4 24 | $2.0B | $2.0B | ||
| Q3 24 | $2.0B | $2.0B | ||
| Q2 24 | $2.0B | $2.0B |
总资产FDPICUI
| Q1 26 | $3.4B | — | ||
| Q4 25 | $3.1B | $4.1B | ||
| Q3 25 | $3.1B | $4.1B | ||
| Q2 25 | $3.2B | $4.1B | ||
| Q1 25 | $3.2B | $4.2B | ||
| Q4 24 | $3.1B | $4.2B | ||
| Q3 24 | $3.2B | $4.3B | ||
| Q2 24 | $3.1B | $4.3B |
负债/权益比FDPICUI
| Q1 26 | 0.22× | — | ||
| Q4 25 | 0.09× | — | ||
| Q3 25 | 0.09× | — | ||
| Q2 25 | 0.10× | — | ||
| Q1 25 | 0.12× | — | ||
| Q4 24 | 0.13× | — | ||
| Q3 24 | 0.14× | — | ||
| Q2 24 | 0.15× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $44.1M | $60.6M |
| 自由现金流经营现金流 - 资本支出 | — | $36.0M |
| 自由现金流率自由现金流/营收 | — | 6.6% |
| 资本支出强度资本支出/营收 | 1.4% | 4.6% |
| 现金转化率经营现金流/净利润 | 4.12× | — |
| 过去12个月自由现金流最近4个季度 | — | $91.8M |
8季度趋势，按日历期对齐
经营现金流FDPICUI
| Q1 26 | $44.1M | — | ||
| Q4 25 | $10.9M | $60.6M | ||
| Q3 25 | $75.0M | $56.7M | ||
| Q2 25 | $113.1M | $11.2M | ||
| Q1 25 | $46.1M | $51.3M | ||
| Q4 24 | $-4.7M | $40.2M | ||
| Q3 24 | $43.5M | $36.1M | ||
| Q2 24 | $125.0M | $82.0M |
自由现金流FDPICUI
| Q1 26 | — | — | ||
| Q4 25 | $-17.2M | $36.0M | ||
| Q3 25 | $60.9M | $27.6M | ||
| Q2 25 | $101.5M | $-8.5M | ||
| Q1 25 | $36.1M | $36.7M | ||
| Q4 24 | $-22.3M | $16.1M | ||
| Q3 24 | $30.1M | $16.2M | ||
| Q2 24 | $117.0M | $62.5M |
自由现金流率FDPICUI
| Q1 26 | — | — | ||
| Q4 25 | -1.7% | 6.6% | ||
| Q3 25 | 6.0% | 5.1% | ||
| Q2 25 | 8.6% | -1.5% | ||
| Q1 25 | 3.3% | 6.1% | ||
| Q4 24 | -2.2% | 2.6% | ||
| Q3 24 | 3.0% | 2.7% | ||
| Q2 24 | 10.3% | 10.5% |
资本支出强度FDPICUI
| Q1 26 | 1.4% | — | ||
| Q4 25 | 2.8% | 4.6% | ||
| Q3 25 | 1.4% | 5.4% | ||
| Q2 25 | 1.0% | 3.6% | ||
| Q1 25 | 0.9% | 2.4% | ||
| Q4 24 | 1.7% | 3.8% | ||
| Q3 24 | 1.3% | 3.4% | ||
| Q2 24 | 0.7% | 3.3% |
现金转化率FDPICUI
| Q1 26 | 4.12× | — | ||
| Q4 25 | 0.34× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 1.99× | 0.32× | ||
| Q1 25 | 1.48× | — | ||
| Q4 24 | -0.23× | — | ||
| Q3 24 | 1.03× | — | ||
| Q2 24 | 2.33× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
FDP
暂无分部数据
ICUI
| Infusion Consumables | $284.7M | 53% |
| Infusion Systems | $176.3M | 33% |
| Vital Care | $79.7M | 15% |
